首页> 外国专利> Pharmaceutical composition comprising Losartan for treating or preventing statin based drug-induced muscle toxicity

Pharmaceutical composition comprising Losartan for treating or preventing statin based drug-induced muscle toxicity

机译:包含洛沙坦的药物组合物,用于治疗或预防他汀类药物引起的肌肉毒性

摘要

A pharmaceutical composition comprising losartan or a pharmaceutically acceptable salt thereof, which is capable of treating or preventing side effects such as muscle toxicity caused by administering a statin-based lipid-lowering drug, and a pharmaceutical combination composition comprising a statin drug and a losartan drug as active ingredients are provided. The pharmaceutical composition comprising losartan or a pharmaceutically acceptable salt thereof provides an effect on treating or preventing muscle-related side effects caused by administration of a statin drug for treating hyperlipidemia, as well as an intrinsic pharmacological effect for treating or preventing hypertension. When administered along with a statin drug in sequence or co-administered at the same time with the statin drug, the pharmaceutical composition can exhibit an effect of effectively or significantly decreasing or preventing side effects such as muscle toxicity.
机译:药物组合物,其包含洛沙坦或其药学上可接受的盐,其能够治疗或预防由于施用他汀类降脂药而引起的副作用,例如肌肉毒性,以及包含他汀类药物和洛沙坦药物的药物组合物提供有效成分。包含氯沙坦或其药学上可接受的盐的药物组合物在治疗或预防由他汀类药物用于治疗高脂血症的药物引起的肌肉相关副作用方面具有作用,以及在治疗或预防高血压方面具有内在的药理作用。当与他汀类药物依次给药或与他汀类药物同时给药时,药物组合物可表现出有效或显着降低或预防副作用如肌肉毒性的作用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号